Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.69 |
| ▸ | CA12 | O43570 | 5/20 | 0.58 |
| ▸ | CA1 | P00915 | 5/20 | 0.58 |
| ▸ | CA2 | P00918 | 5/20 | 0.58 |
| ▸ | CA9 | Q16790 | 5/20 | 0.58 |
| ▸ | CA7 | P43166 | 4/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.58 |
| ▸ | RNASEH1 | O60930 | 1/20 | 0.55 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.55 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.55 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.55 |
| ▸ | HCAR1 | Q9BXC0 | 3/20 | 0.48 |
| ▸ | CA6 | P23280 | 4/20 | 0.46 |
| ▸ | CA4 | P22748 | 3/20 | 0.46 |
| ▸ | CA3 | P07451 | 2/20 | 0.46 |
| ▸ | CA5A | P35218 | 2/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.46 |
| ▸ | TYR | P14679 | 1/20 | 0.46 |
| ▸ | DRD1 | P21728 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1403567 | 0.91 | MEN1 (0.82) | MEN1KMT2ACA12CA1CA2 | |
| SCHEMBL21713201 | 0.88 | MEN1 (0.78) | MEN1KMT2ACA12CA1CA2 | |
| SCHEMBL13960184 | 0.84 | MEN1 (0.72) | MEN1KMT2ACA12CA1CA2 | |
| SCHEMBL1901737 | 0.82 | MEN1 (1.00) | MEN1KMT2ACA12CA1CA2 | |
| SCHEMBL13960185 | 0.82 | MEN1 (0.69) | MEN1KMT2ACA12CA1CA2 | |
| SCHEMBL1527153 | 0.80 | MEN1 (0.67) | MEN1KMT2ACA12CA1CA2 | |
| SCHEMBL124871 | 0.80 | CYP1A2 (0.48) | MEN1KMT2ACA12CA1CA2 | |
| SCHEMBL29357264 | 0.77 | MEN1 (0.66) | MEN1KMT2ACA12CA1CA2 | |
| SCHEMBL9944055 | 0.77 | MEN1 (0.66) | MEN1KMT2ACA12CA1CA2 | |
| SCHEMBL44327 | 0.77 | MEN1 (0.66) | MEN1KMT2ACA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062513-A1 | LIQUID CRYSTAL POLYMER PARTICLE, MANUFACTURING METHOD THEREOF AND POLYIMIDE FILM USING THE SAME | TAIMIDE TECHNOLOGY INCORPORATION (TW) | 2026-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062513-A1 | LIQUID CRYSTAL POLYMER PARTICLE, MANUFACTURING METHOD THEREOF AND POLYIMIDE FILM USING THE SAME | ACR, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, H1-10 | MEN1 2288/4885KMT2A 621/4885CA12 407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.